Industries > Pharma > Global Blood Cancer Market Forecast to 2028

Global Blood Cancer Market Forecast to 2028

Immunotherapy, Chemotherapy, Targeted Therapy

PUBLISHED: 11 April 2019
PAGES: 92
PRODUCT CODE: PHA0412
SUBMARKET: Therapeutic Drugs

Clear
WOOCS 2.2.1
DOWNLOAD SAMPLE
SKU: PHA0412 Categories: , Tags: , ,

The global blood cancer market reached $24bn in 2018 and is estimated to grow at a CAGR of 6.4% in the first half of the forecast period. Chemotherapy held 44% of the market in 2018.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand-new report you will receive 61 charts – all unavailable elsewhere.

This report provides clear detailed insight into the global blood cancer market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

• Revenue and growth forecasts to 2028 for the blood cancer market

• Revenue and growth forecast to 2028 for the blood cancer market by type of therapy:
• Chemotherapy
• Targeted therapy
• Immunotherapy

• Revenue and growth forecast to 2028 for the blood cancer market by regional and national market:
• The US
• Japan
• Germany
• France
• The UK
• Spain
• Italy
• Brazil
• Russia
• India
• China

Global Blood Cancer Market Forecast to 2028

For each national market, the revenue forecast is also broken down by submarket.

• For each national market, this report provides incident cases projection from 2018 to 2028 for:
• Leukaemia
• Non-Hodgkin Lymphoma
• Hodgkin Lymphoma
• Multiple Myeloma

• Discussion and profiles of the leading players in the blood cancer market:
• Amgen
• AstraZeneca
• Bayer
• Bristol-Myers Squibb (BMS)
• Celgene
• Johnson & Johnson
• Novartis
• Pfizer
• Roche

• Discussion on drugs that are currently in the R&D pipeline for Leukaemia, Lymphoma and Multiple Myeloma.

• Analysis of what stimulates and restrains the global blood cancer market: Porter’s Five Forces Analysis, Trends, Drivers and Challenges

• Key Questions Answered by this Report:
• How is the Blood Cancer market evolving?
• What are the drivers and restraints for the growth of the Blood Cancer market?
• How will each Blood Cancer submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2028?
• What will be the main driver for the overall market to 2028?
• How will political and regulatory factors influence the regional markets and submarkets?
• Will leading national Blood Cancer markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2028 and which geographical region will lead the market in 2028?
• Who are the leading players and what are their prospects over the forecast period?

Visiongain’s study is intended for anyone requiring commercial analyses for the global blood cancer market. You find data, trends and predictions.

Buy our report today Global Blood Cancer Market Forecast to 2028: Immunotherapy, Chemotherapy, Targeted Therapy.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

1. Report Overview
1.1 Global Blood Cancer Market Overview
1.2 Why You Should Read This Report
1.3 How This Report Delivers
1.4 Why You Should Read This Report
1.5 How This Report Delivers
1.6 Key Questions Answered by This Analytical Report
1.7 Who is This Report For?
1.8 Methodology
1.8.1 Primary Research
1.8.2 Secondary Research
1.8.3 Market Evaluation & Forecasting Methodology
1.9 Frequently Asked Questions (FAQ)
1.10 Associated Visiongain Reports
1.11 About Visiongain

2. The Global Blood Cancer Market by Therapy Area: Incident Cases by Country 2018-2018
2.1 Overview of Blood Cancer
2.2 Signs and Symptoms
2.3 Causes of Blood Cancer
2.4 Blood Cancer Treatment & Therapy Options
2.5 Leukaemia
2.5.1 Acute Lymphocytic Leukaemia (ALL) in Adults
2.5.2 Acute Myeloid Leukaemia (AML)
2.5.3 Chronic Lymphocytic Leukaemia (CLL)
2.5.4 Chronic Myeloid Leukaemia (CML)
2.5.5 Chronic Myelomonocytic Leukaemia
2.5.6 Leukaemia in Children
2.5.7 Survival
2.6 Lymphoma
2.6.1 Non-Hodgkin lymphomas
2.6.2 Hodgkin disease
2.6.3 Survival
2.7 Myeloma
2.7.1 Survival

3. The Global Blood Cancer Market by Type of Therapy: Market Forecast to 2028
3.1 An Introduction to Various Types of Therapies
3.2 Chemotherapy
3.2.1 Global Chemotherapy Market Forecast to 2028
3.3.1 Global Targeted Therapy Market Forecast to 2028
3.4 Immunotherapy
3.4.1 Global Immunotherapy Market Forecast to 2028

4. Global Blood Cancer Market by Region: Market Forecast to 2028
4.1 An Introduction to the Market Geography
4.2 United States Blood Cancer Market Forecast to 2028
4.2.1 United States Blood Cancer Market by Disease Type
4.2.2 United States Blood Cancer Market by Type of Therapy: Forecast to 2028
4.3 EU5 Blood Cancer Market Forecast to 2028
4.3.1 EU5 Blood Cancer Market by Disease Type
4.3.2 EU5 Blood Cancer Market Forecast by Type of Therapy: Forecast to 2028
4.3.3 EU5 Blood Cancer Market by Country Share, 2018 and 2028
4.4 BRIC Blood Cancer Market Forecast to 2028
4.4.1 BRIC Blood Cancer Market by Disease Type
4.4.2 BRIC Blood Cancer Market by Type of Therapy: Forecast to 2028
4.4.3 BRIC Countries Blood Cancer Market
4.4.3.1 Brazil
4.4.3.2 India
4.4.3.3 Russia
4.4.3.4 China
4.4 Japan Blood Cancer Market Forecast to 2028
4.4.1 Japan Blood Cancer Market: by Disease Type
4.4.2 Japan Blood Cancer Market by Type of Therapy: Forecast to 2028

5. Leading Companies in the Blood Cancer Market
5.1 Introduction
5.1.1 Amgen Inc.
5.1.1.1 Business Overview
5.1.1.2 Recent Financials
5.1.1.3 Product Offerings
5.1.1.4 Recent developments
5.1.2 AstraZeneca PLC
5.1.2.1 Business Overview
5.1.2.2 Recent Financials
5.1.2.3 Product Offerings
5.1.2.4 Recent developments
5.1.3 Bayer AG
5.1.3.1 Business Overview
5.1.3.2 Recent Financials
5.1.3.3 Product Offerings
5.1.3.4 Recent developments
5.1.4 Bristol-Myers Squibb Company
5.1.4.1 Business Overview
5.1.4.2 Recent Financials
5.1.4.3 Product Offerings
5.1.4.4 Recent developments
5.1.5 Celgene Corporation
5.1.5.1 Business Overview
5.1.5.2 Recent Financials
5.1.5.3 Product Offerings
5.1.5.4 Recent developments
5.1.6 Roche
5.1.6.1 Business Overview
5.1.6.2 Recent Financials
5.1.6.3 Product Offerings
5.1.6.4 Recent developments
5.1.7 Johnson & Johnson
5.1.7.1 Business Overview
5.1.7.2 Recent Financials
5.1.8 Novartis
5.1.8.1 Business Overview
5.1.8.2 Recent Financials
5.1.8.3 Product Offerings
5.1.8.4 Recent developments
5.1.9 Pfizer Inc.
5.1.9.1 Business Overview
5.1.9.2 Recent Financials
5.1.9.3 Product Offerings
5.1.9.4 Recent Developments

6. Blood Cancer: R&D Pipeline
6.1 Blood Cancer: R&D Pipeline
6.1.1 Drugs for Leukemia
6.1.2 Drugs for Lymphoma
6.1.3 Multiple Myeloma
6.1.4 Other Major Drugs Under Different Stages of Development

7. Qualitative Analysis
7.1. Porter’s Five Forces Analysis
7.1.1. Bargaining power of buyers (MEDIUM)
7.1.2 Bargaining power of suppliers (LOW)
7.1.3 Industry rivalry (HIGH)
7.1.4 Threat of new entrants
7.1.5 Threat of substitutes (HIGH)
7.2 Market Dynamics of Blood Cancer Market
7.2.1 Trends
7.2.2 Drivers
7.2.3 Challenges

8. Conclusions & Recommendations
8.1 Key Takeaway
8.2 Conclusion

Appendices
Associated Visiongain Reports
Visiongain Report Sales Order Form
About Visiongain
Visiongain Report Evaluation Form

List of Tables
Table 2.1 Incident Cases of Leukaemia by Country: 2018-2028
Table 2.2 Incident cases of Non-Hodgkin Lymphoma (NHL) by Country: 2018-2028
Table 2.3 Incident Cases of Hodgkin Lymphoma (HL) by Country: 2018-2028
Table 2.4 Incident cases of Multiple Myeloma by Country: 2018-2028
Table 3.1 Global Blood Cancer Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2018-2028
Table 3.2 Global Chemotherapy Market Forecast 2018-2028: Revenue ($bn), AGR (%), CARG (%), 2018-2028
Table 3.3 Global Targeted Therapy Market Forecast 2018-2028: Revenue ($bn), AGR (%), CAGR (%)
Table 3.4 Global Immunotherapy Market Forecast 2018-2028: Revenue ($bn), AGR (%), CAGR (%)
Table 4.1 United States Blood Cancer Market Forecast 2018-2028: Revenue ($bn), AGR (%), CAGR (%)
Table 4.2 Incident Cases of Different Types of Cancers in the US: 2018-2028
Table 4.3: United States Blood Cancer Market Forecast by Type of Therapy: Revenue ($bn), AGR (%), CAGR (%)
Table 4.4 EU5 Blood Cancer Market Forecast 2018-2028: Revenue ($bn), AGR (%), CAGR (%)
Table 4.5 Incident Cases of Different Types of Cancers in the EU5
Table 4.6 EU5 Blood Cancer Market Forecast by Type of Therapy: Revenue ($bn), AGR (%), CAGR (%)
Table 4.7 BRIC Blood Cancer Market Forecast 2018-2028 by Country: Revenue ($bn), AGR (%), CAGR (%)
Table 4.8 Incident Cases of Different Types of Cancers in BRIC Countries: 2018-2028
Table 4.9 BRIC Countries Blood Cancer Market Forecast by Type of Therapy: Revenue ($bn), 2018-2028
Table 4.10 Japan Blood Cancer Market Forecast 2018-2028: Revenue ($bn), AGR (%), CAGR (%)
Table 4.11 Incident Cases of Different Types of Cancers in Japan: 2018-2028
Table 4.12 Japan Blood Cancer Market Forecast by Type of Therapy: Revenue ($bn), 2018-2028
Table 5.1 Amgen Inc.: Key Facts
Table 5.2 Amgen Inc.: Financial Information 2016-2017
Table 5.3 AstraZeneca PLC: Key Facts
Table 5.4 AstraZeneca PLC: Financial Information 2016-2017
Table 5.5 Bayer AG: Key Facts
Table 5.6 Bayer AG: Recent Financials 2016-2017
Table 5.7 Bristol-Myers Squibb Company – Key Facts
Table 5.8 Bristol-Myers Squibb: Recent Financials 2016-2017
Table 5.9 Celgene Corporation: Key Facts
Table 5.10 Celgene: Recent Financials 2016-2017
Table 5.11 Roche: Key Facts
Table 5.12 Roche: Recent Financials 2016-2017
Table 5.13 Johnson & Johnson: Key Facts
Table 5.14 Johnson & Johnson: Recent Financials 2016-2017
Table 5.15 Novartis AG: Key Facts
Table 5.16 Novartis: Recent Financials 2016-2017
Table 5.17 Pfizer Inc.: Key Facts
Table 5.18 Pfizer Inc.: Recent Financials 2016-2017
Table 6.1 Major Drugs Udder Development

List of Figures
Figure 2.1 Types of Blood Cancer
Figure 2.2 Different Types of Leukaemia
Figure 2.3 Trend of Leukaemia Cases by Country: 2018-2028
Figure 2.4 Trend of Non-Hodgkin Lymphoma (NHL) by Country: 2018-2028
Graph 2.5 Trend of Hodgkin Lymphoma (NHL) by Country: 2018-2028
Figure 2.6 Trend of Multiple Myeloma by Country: 2018-2028
Figure 3.1 Market Size of Cancer Therapy by Type ($bn): 2018-2028
Figure 3.2 Market share (%) of Cancer Therapy by Type: 2018 and 2028
Figure 3.3: Global Chemotherapy Market Forecast 2018-2028: Revenue ($bn), AGR (%)
Figure 3.4 Global Targeted Therapy Market Forecast 2018-2028: Revenue ($bn), AGR (%)
Figure 3.5 Global Immunotherapy Market Forecast 2018-2028: Revenue ($bn), AGR (%)
Figure 4.1 Blood Cancer Market by Region: % Share, 2018
Figure 4.2 Blood Cancer Market by Region: % Share, 2028
Figure 4.3: United States Blood Cancer Market Forecast 2018-2028: Revenue ($bn), AGR (%)
Figure 4.4: Distribution of Different Types of Blood Cancer in the US: 2018-2028
Figure 4.5: EU5 Blood Cancer Market Forecast 2018-2028: Revenue ($bn), AGR (%)
Figure 4.6 EU5 Blood Cancer Market by Country: % Share, 2018 and 2028
Figure 4.7: BRIC Blood Cancer Market Forecast 2018-2028: Revenue ($bn), AGR (%)
Figure 4.8: Japan Blood Cancer Market Forecast 2018-2028: Revenue ($bn), AGR (%)
Figure 4.9: Distribution of Different Types of Blood Cancer in Japan: 2018-2028
Figure 8.1: Global Blood Cancer Market by Region: Revenue ($bn), 2018
Figure 8.2: Global Blood Cancer Market by Region: Revenue ($bn), 2018
Acceleron Pharma, Inc.
Acerta Pharma
Advantagene, Inc
Agios Pharmaceuticals, Inc.
Alcon
Amgen
Array BioPharma
AstraZeneca
Bayer AG
Bayer HealthCare Pharmaceuticals Inc
BeiGene, Ltd
Bicycle Therapeutics
BioSight
bluebird bio, Inc.
Bristol-Myers Squibb (BMS)
Celgene
Evotec AG
Fate Therapeutics
Food and Drug Administration (FDA)
FORMA Therapeutics Holdings, LLC
Forty Seven, Inc.
Genentech
GlaxoSmithKline
Hoffmann-La Roche
Hospira, Inc.
Illumina, Inc.
Janssen Pharmaceuticals, Inc.
Johnson & Johnson
Jounce Therapeutics, Inc.
Juno Therapeutics, Inc.
Lycera Corp.
MacroGenics
NantBioScience, Inc.
National Health Service (NHS)
Nektar Therapeutics
Novartis
Nurix Inc.
OncoMed Pharmaceuticals, Inc.
Pfizer
Prothena Corporation plc
Roche
Servizio Sanitario Nazionale (SSN)
Skyhawk Therapeutics, Inc.
Surface Oncology
Sutro Biopharma, Inc.
The University of Texas MD Anderson Cancer Center
U.S. Department of Energy
UCB
Vividion Therapeutics, Inc.
Zoetis Inc.
Zymeworks Inc.

Download sample pages

Complete the form below to download your free sample pages for Global Blood Cancer Market Forecast to 2028


Download sample pages

Complete the form below to download your free sample pages for Global Blood Cancer Market Forecast to 2028


Do you have any custom requirements we can help you with?

Any specific country, geo region, market segment or specific company information?

Email us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

facebookWin a Free Visiongain Pharma report – ‘Like’ our Pharma Facebook page with the link below and enter into our raffle to win a free, unlocked Visiongain report, choosing your relevant report from our reports selection.

Click here to ‘Like’ our Facebook page https://www.facebook.com/V.G.Pharma/

Would you like a free report overview of the report of your choice?

If so, please drop an email to Sara Peerun stating your chosen report title to sara.peerun@visiongain.com

Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email sara.peerun@visiongain.com
Would you like to get the latest Visiongain pharma reports catalogue?

What are the dynamic growth sectors? where are the regional business opportunities?

Which technologies will prevail and who are the leading companies succeeding in these sectors and why?

If you want definitive answers to business critical questions, discover Visiongain’s full range of business intelligence reports.

If so, please email Sara Peerun on sara.peerun@visiongain.com or call her today on +44 (0) 20 7549 9987

  • Human Microbiome Therapeutics Market 2019-2029
  • Top 20 Urology Companies 2019
  • Global Antidepressant and Anti-Anxiety Drugs Market Forecasts 2019-2029
  • The Top 100 In-Vitro Diagnostics Companies to Watch 2019
  • Global Hypertension Drugs Market 2019-2029
  • The Next Generation Sequencing Market 2019-2029
  • Lyophilisation for Pharmaceuticals: Products and Services 2019-2029
  • Top 25 In Vitro Diagnostics (IVD) Companies 2019
  • Global Anti-Idiopathic Pulmonary Fibrosis Drugs Market 2019-2029
  • Global Biomarkets and Technologies Market 2019-2029
American Association of Colleges of Pharmacy
American College of Clinical Pharmacy
American Pharmacists Association
American Society for Pharmacy Law
American Society of Consultant Pharmacists
American Society of Health-System Pharmacists
Association of Special Pharmaceutical Manufacturers
Australian College of Pharmacy
Biotechnology Industry Organization
Canadian Pharmacists Association
Canadian Society of Hospital Pharmacists
Chinese Pharmaceutical Association
College of Psychiatric and Neurologic Pharmacists
Danish Association of Pharmaconomists
European Association of Employed Community Pharmacists in Europe
European Medicines Agency
Federal Drugs Agency
General Medical Council
Head of Medicines Agency
International Federation of Pharmaceutical Manufacturers & Associations
International Pharmaceutical Federation
International Pharmaceutical Students’ Federation
Kuwait Pharmaceutical Association
Medicines and Healthcare Products Regulatory Agency
National Pharmacy Association
Norwegian Pharmacy Association
Ontario Pharmacists Association
Pakistan Pharmacists Association
Pharmaceutical Association of Mauritius
Pharmaceutical Group of the European Union
Pharmaceutical Society of Australia
Pharmaceutical Society of Ireland
Pharmaceutical Society Of New Zealand
Pharmaceutical Society of Northern Ireland
Professional Compounding Centers of America
Royal Pharmaceutical Society
The American Association of Pharmaceutical Scientists
The BioIndustry Association
The Controlled Release Society
The European Federation of Pharmaceutical Industries and Associations
The European Generic Medicines Association
The European Personalised Medicine Association
The Institute of Clinical Research
The International Society for Pharmaceutical Engineering
The Pharmaceutical Association of Israel
The Pharmaceutical Research and Manufacturers of America
The Pharmacy Guild of Australia
The Society of Hospital Pharmacists of Australia

Latest Pharma news

“Biobanking market set to grow to $4.2bn by 2024” says new Visiongain report

Biobanking infrastructure is improving at a global level with the establishment of large-scale national biobanks, population biobank projects, virtual biobanks and networking at national and international level.

23 May 2019

READ

“Global Urology Devices market set to grow to $9.3bn by 2023” says new Visiongain report

The market is driven by a number of factors such as aging population, technological advancements, and increasing awareness programs.

21 May 2019

READ

“In Vitro Diagnostics (IVD) market set to grow to $91bn by 2024” says new Visiongain report

In recent years, the IVD market has experienced increased consolidation among industry participants, with significant merger and acquisition (M&A) activity, especially among larger companies as they diversify and manoeuvre for stronger positions.

14 May 2019

READ

“Indian Pharmaceutical market set to grow to $71bn by 2024” says new Visiongain report

Expected increases in the level of healthcare coverage will allow greater proportion of the population to be able to afford medical care, which is still mostly paid for out-of-pocket by patients, as a greater amount of people have health insurance to cover their medical expenses.

09 May 2019

READ

Categories

Category